FIELD: medicine; pharmacy.
SUBSTANCE: invention relates to pharmaceutical compositions having neuroprotective activity in the form of a tablet, dispersed in the oral cavity containing hexamethylene amide bis-(N-monosuccinyl-L-glutamyl-L-lysine) as an active substance. Effect of the composition is shown on the model of haloperidol catalepsy. Suggested tablets meet the requirements of State Pharmacopeia XIII.
EFFECT: technical result of the invention is higher efficiency of using hexamethylene amide bis-(N-monosuccinyl-L-glutamyl-L-lysine) by creating pharmaceutical compositions, having neuroprotective action; wider range of neuroprotective agents dispersed in the oral cavity.
15 cl, 11 ex, 3 tbl, 1 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION OF NEUROPROTECTIVE ACTION FOR PARENTERAL APPLICATION ON BASIS OF HEXAMETHYLENEDIAMINE BIS-(N-MONOSUCCINYL-L-GLUTAMIL-L-LYSINE) IN LYOPHILIZED DOSAGE FORM | 2017 |
|
RU2678203C2 |
| PHARMACEUTICAL COMPOSITION BASED ON BIS-(N-MONOSUCCINYL-L-SERYL-L-LYSINE) HEXAMETHYLENEDIAMIDE (GSB-106) | 2018 |
|
RU2697254C1 |
| METHOD FOR PRODUCING PHARMACEUTICAL COMPOSITION BASED ON HEXAMETHYLENEDIAMIDE BIS-(N-MONOSUCINYL-L-SERYL-L-LYSINE) | 2021 |
|
RU2790827C1 |
| DRUG PREPARATION WITH ANTIARRHYTHMIC AND ANTIFIBRILLATORY ACTION | 2010 |
|
RU2477144C2 |
| HEPATOPROTECTIVE EFFECT OF LOW MOLECULAR WEIGHT MIMETICS NGF | 2022 |
|
RU2790828C1 |
| SUBSTANCE WITH ANGIOGENIC ACTIVITY | 2013 |
|
RU2613184C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING MEMANTINE AND MELATONIN COMBINATION | 2016 |
|
RU2623865C1 |
| SMALL MOLECULES WITH NGF-LIKE ACTIVITY AND ANTIDIABETIC PROPERTIES | 2013 |
|
RU2613314C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING THE COMBINATION OF MEMANTINE AND MELATONIN | 2016 |
|
RU2654713C1 |
| SUBSTANCE WITH ANTI-ANGIOGENIC ACTIVITY | 2013 |
|
RU2625752C2 |
